We are live on ! Find out more
Corient Private Wealth

Corient Private Wealth Portfolio holdings

AUM $72.2B
1-Year Est. Return 27.85%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+27.85%
3 Year Est. Return
+84.7%
5 Year Est. Return
10 Year Est. Return
AUM
$73.5B
AUM Growth
+$10.1B
Cap. Flow
+$7.59B
Cap. Flow %
10.32%
Top 10 Hldgs %
27.78%
Holding
2,833
New
284
Increased
1,456
Reduced
778
Closed
191

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$469M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$392M
3
MSFT icon
Microsoft
MSFT
+$354M
4
NVDA icon
NVIDIA
NVDA
+$329M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$283M

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.23%
2 Technology 19.35%
3 Financials 10.37%
4 Healthcare 7.34%
5 Consumer Discretionary 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENVR
2601
Gen Digital Inc Contingent Value Rights
GENVR
$45.7K ﹤0.01%
10,100
NXXT
2602
NextNRG Inc
NXXT
$19M
$43.5K ﹤0.01%
+3,000
New +$51.8K
COTY icon
2603
Coty
COTY
$2.33B
$42.8K ﹤0.01%
+13,884
New +$50.5K
RZLV
2604
Rezolve AI
RZLV
$950M
$42.3K ﹤0.01%
16,450
+3,150
+24% +$11.9K
EGY icon
2605
Vaalco Energy
EGY
$686M
$42K ﹤0.01%
11,549
-40
-0.3% -$148
DTIL icon
2606
Precision BioSciences
DTIL
$182M
$41.6K ﹤0.01%
10,000
AMC icon
2607
AMC Entertainment Holdings
AMC
$2.28B
$41.3K ﹤0.01%
+26,449
New +$63.1K
INTS icon
2608
Intensity Therapeutics
INTS
$12.4M
$41K ﹤0.01%
+4,000
New +$40.6K
CCCC icon
2609
C4 Therapeutics
CCCC
$422M
$40.9K ﹤0.01%
21,387
-1,315
-6% -$3.12K
ABAT icon
2610
American Battery Technology Co
ABAT
$319M
$40.3K ﹤0.01%
12,055
+1,843
+18% +$8.63K
HITI
2611
High Tide
HITI
$226M
$39.8K ﹤0.01%
15,000
-5,000
-25% -$14.8K
FATE icon
2612
Fate Therapeutics
FATE
$282M
$29.3K ﹤0.01%
+29,830
New +$35.8K
NAK
2613
Northern Dynasty Minerals
NAK
$708M
$26.1K ﹤0.01%
13,250
XRX icon
2614
Xerox
XRX
$454M
$25.7K ﹤0.01%
10,851
-38,225
-78% -$113K
COCH icon
2615
Envoy Medical
COCH
$55M
$25.2K ﹤0.01%
38,162
SMTK
2616
SmartKem
SMTK
$1.38M
$24.5K ﹤0.01%
346
-40
-10% -$3.58K
THM
2617
International Tower Hill Mines
THM
$615M
$23.3K ﹤0.01%
12,500
ORBS
2618
Eightco Holdings
ORBS
$369M
$23K ﹤0.01%
+13,320
New +$62.5K
GEVO icon
2619
Gevo
GEVO
$388M
$22.9K ﹤0.01%
11,450
QUCY
2620
Quantum Cyber N.V.
QUCY
$110M
$22.4K ﹤0.01%
+20,000
New +$26.3K
CNTX icon
2621
Context Therapeutics
CNTX
$33.5M
$22.2K ﹤0.01%
+15,084
New +$17.6K
CERS icon
2622
Cerus
CERS
$504M
$20.9K ﹤0.01%
+10,138
New +$17.6K
BYND icon
2623
Beyond Meat
BYND
$172M
$20K ﹤0.01%
794
MGNX icon
2624
MacroGenics
MGNX
$257M
$19K ﹤0.01%
11,822
-2,802
-19% -$4.41K
GETY icon
2625
Getty Images
GETY
$94.9M
$18.6K ﹤0.01%
+13,917
New +$23.9K

Similar funds

Corient Private Wealth's Q4 2025 Portfolio in Review

As of Q4 2025, Corient Private Wealth held 2,833 positions worth $73.5B, up 16% from $63.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Corient Private Wealth deployed $7.59B of net new capital in Q4 2025, opening 284 new positions and adding to 1,456 existing holdings. Its largest new stake was Akre Focus ETF: 686,029 shares worth $44.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI Intl Quality Factor ETF, an estimated $109M trimmed.

  • Corient Private Wealth's largest Q4 2025 buy was Akre Focus ETF: 686,029 shares worth $44.9M.
  • Corient Private Wealth added most to Apple in Q4 2025, an estimated $469M increase.
  • Corient Private Wealth's biggest Q4 2025 reduction was iShares MSCI Intl Quality Factor ETF, cutting an estimated $109M.
  • Corient Private Wealth fully exited Invesco QQQ Trust in Q4 2025, selling an estimated $350M.
  • Corient Private Wealth's ten largest holdings make up 28% of its $73.5B portfolio in Q4 2025.
  • Corient Private Wealth opened 284 new positions and closed 191 in Q4 2025.
  • Corient Private Wealth's portfolio value rose 16% quarter-over-quarter to $73.5B.

Based on Corient Private Wealth's 13F filing for Q4 2025, filed 19 Feb 2026.